Scotiabank Issues Negative Outlook for OR Royalties Earnings

OR Royalties Inc. (NYSE:OR) – Research analysts at Scotiabank dropped their FY2026 EPS estimates for OR Royalties in a research report issued on Wednesday, July 15th. Scotiabank analyst T. Jakusconek now forecasts that the basic materials company will post earnings per share of $1.24 for the year, down from their prior forecast of $1.26. Scotiabank currently has a “Sector Perform” rating and a $42.00 target price on the stock. The consensus estimate for OR Royalties’ current full-year earnings is $1.34 per share.

OR Royalties (NYSE:OR) last announced its quarterly earnings data on Wednesday, May 6th. The basic materials company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.06. OR Royalties had a net margin of 78.09% and a return on equity of 15.10%. The business had revenue of $102.83 million for the quarter, compared to analyst estimates of $103.27 million.

Several other brokerages have also recently commented on OR. Royal Bank Of Canada cut their price target on shares of OR Royalties from $50.00 to $45.00 and set an “outperform” rating on the stock in a research report on Thursday, July 9th. Weiss Ratings cut OR Royalties from a “buy (b)” rating to a “buy (b-)” rating in a report on Thursday, June 4th. Wall Street Zen downgraded OR Royalties from a “buy” rating to a “hold” rating in a research report on Saturday, June 6th. Jefferies Financial Group lowered their target price on OR Royalties from $40.00 to $34.00 and set a “hold” rating on the stock in a research report on Monday, July 6th. Finally, Zacks Research lowered OR Royalties from a “hold” rating to a “strong sell” rating in a report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, OR Royalties currently has an average rating of “Moderate Buy” and an average target price of $40.50.

OR Royalties Trading Down 0.2%

OR Royalties stock opened at $28.25 on Monday. The company has a market cap of $5.29 billion, a P/E ratio of 21.08 and a beta of 0.74. OR Royalties has a 1-year low of $27.07 and a 1-year high of $48.06. The company has a fifty day simple moving average of $33.72 and a 200 day simple moving average of $38.09.

OR Royalties Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Tuesday, June 30th were given a $0.065 dividend. This is a boost from OR Royalties’s previous quarterly dividend of $0.06. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.9%. OR Royalties’s payout ratio is 18.66%.

Institutional Investors Weigh In On OR Royalties

Institutional investors and hedge funds have recently modified their holdings of the company. Grove Bank & Trust acquired a new stake in OR Royalties in the 2nd quarter valued at about $32,000. Groupe la Francaise increased its position in OR Royalties by 122.2% during the first quarter. Groupe la Francaise now owns 200,000 shares of the basic materials company’s stock worth $7,591,000 after buying an additional 110,000 shares during the last quarter. Bank of America Corp DE increased its position in OR Royalties by 37.4% during the first quarter. Bank of America Corp DE now owns 1,008,086 shares of the basic materials company’s stock worth $38,327,000 after buying an additional 274,486 shares during the last quarter. Janus Henderson Group PLC raised its stake in OR Royalties by 63.0% in the first quarter. Janus Henderson Group PLC now owns 29,276 shares of the basic materials company’s stock valued at $1,130,000 after buying an additional 11,311 shares during the period. Finally, Amundi raised its stake in OR Royalties by 8.4% in the first quarter. Amundi now owns 1,151,071 shares of the basic materials company’s stock valued at $43,764,000 after buying an additional 89,202 shares during the period. 68.52% of the stock is owned by institutional investors.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.